Sandoz Group AG
SDZ
Classifica tra le azioni
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Prezzo delle azioni
$96.21
Capitalizzazione di mercato
$41.63B
Variazione (1 giorno)
1.02%
Variazione (1 anno)
58.97%
Paese
CH
Scambia Sandoz Group AG (SDZ)
Categoria
Healthcare
Rapporto P/S per Sandoz Group AG (SDZ)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sandoz Group AG, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Sandoz Group AG da 2020 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2025 | 2.82 | 46.06% |
| 2024 | 1.93 | 39.23% |
| 2023 | 1.39 | -13.02% |
| 2022 | 1.59 | 0.98% |
| 2021 | 1.58 | -6.03% |
| 2020 | 1.68 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 2.19 | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | - |
IN
|
